Becker's Spine Review reports on how disc replacement technology has seen significant growth from ongoing research and product developments in 2022. 

HSS is part of a multicenter trial examining the effectiveness of three disc replacement devices used for two-level symptomatic cervical disc disease. Researchers are comparing Centinel Spine's Prodisc C SK and Prodisc C Vivo to Zimmer Biomet's Mobi-C cervical disc in the treatment of two-level symptomatic cervical disc disease. 

Read the full article: https://www.beckersspine.com/